Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Hypnotics Stories

2011-01-26 08:26:02

By Rhonda Craig, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- A new report shows that brief counseling sessions can help improve insomnia in older adults. According to background information in the article, insomnia affects anywhere from 15 to 35 percent of older adults. For the research, Daniel J. Buysse, M.D., of the University of Pittsburgh School of Medicine, and his colleagues, conducted a randomized clinical trial that involved 79 insomniacs (all over the age of 60). Thirty-nine...

2011-01-13 14:55:04

Adults who take one of the world's most commonly prescribed sleep medications are significantly more at risk for nighttime falls and potential injury, according to a new study by the University of Colorado at Boulder. The study, which involved 25 healthy adults, showed 58 percent of the older adults and 27 percent of the young adults who took a hypnotic, sleep-inducing drug called zolpidem showed a significant loss of balance when awakened two hours after sleep. The findings are important...

2011-01-10 15:37:43

Most anti-epileptic drugs are associated with an increased risk of non-traumatic fracture in individuals 50 years of age and older, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals. Anti-epileptic drugs are considered a secondary risk factor for osteoporosis, according to background information in the article, because epilepsy is highly prevalent in older adults, a population already at risk for osteoporosis. Additionally, anti-epileptic...

2010-12-14 00:01:26

Handa Pharmaceuticals, LLC ("Handa"), a specialty pharmaceutical company based in Fremont, California, today announced that the U.S. Food and Drug Administration ("FDA") has granted tentative approval of the Company's Abbreviated New Drug Application ("ANDA") for Quetiapine Fumarate Extended-Release Tablets, 50 mg., 150 mg., 200 mg., 300 mg., and 400 mg., a generic version of AstraZeneca's SEROQUEL XR®. Fremont, CA (PRWEB) December 13, 2010 Handa Pharmaceuticals, LLC ("Handa"), a...

2010-11-22 16:09:19

New study links high prevalence of insomnia and poor quality of life in software engineers Insomnia is bad news for software engineers' quality of life and deserves greater recognition and attention, according to new research by Sara Sarrafi Zadeh and Khyrunnisa Begum from the University of Mysore in India. Their work shows that poor sleep has a bearing on quality of life - affecting physical and mental health in particular - in this group with high levels of job-related stress. Their paper...

2010-11-16 10:39:00

BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that first-line use of Bristol Myers-Squibb/Otsuka's Abilify has increased over the past year in newly-diagnosed patients from 4.1 percent patient share to 8.8 percent. According to Treatment Algorithms in Bipolar Disorder, uptake of Abilify in the first-line will continue among surveyed primary care physicians (PCPs):...

2010-11-08 14:54:26

When sleep doesn't come easily, some people turn to what they think is an easy solution "“ sleeping pills. But according to a Baylor College of Medicine sleep expert, sleep medications "“ whether prescription or over-the-counter "“ shouldn't be taken lightly. "All medications have side effects that need to be weighed whenever you take them," cautioned Dr. Phil Alapat, assistant professor of pulmonary, critical care and sleep medicine at BCM and medical director of the BCM...

2010-10-25 10:23:00

Increased Enforcement This Week as Crashes Involving Suspected Drugged Drivers on Rise HARRISBURG, Pa., Oct. 25 /PRNewswire-USNewswire/ -- PennDOT and the Pennsylvania State Police are reminding motorists that driving while under the influence of prescription and over-the-counter medication can be just as dangerous as driving under the influence of alcohol and illegal drugs. PennDOT will work with state and municipal police departments throughout Halloween week to step up...

2010-10-21 12:00:00

BURLINGTON, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next three years, Bristol Myers-Squibb/Otsuka's Abilify, and AstraZeneca's Seroquel XR will be the fastest-growing drugs in terms of prescriptions for the treatment of major depression. According to Treatment Algorithms in Major Depressive Disorder, the largest gains in market share for major depressive disorder...

2010-10-19 05:30:00

ANAHEIM, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release financial results for the third quarter ended September 30, 2010 on Thursday, October 28, 2010 after the market close. The Company will host a conference call and webcast on Thursday, October 28, 2010 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's third quarter results and current corporate developments. The dial-in number for the...